SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹176 Cr | ₹123 Cr | ₹138 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹138 Cr |
How is Total Non-Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹176 Cr | 43.07 | |
| Mar2024 | ₹123 Cr | -11.15 | |
| Mar2023 | ₹138 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,716.6 Cr | -0.3% | 31.8% | 45.9% | Stock Analytics | |
| SAGILITY | ₹18,748.7 Cr | 0.3% | -3.4% | -0.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,900.7 Cr | -2.2% | -5.7% | -33.2% | Stock Analytics | |
| PRIME FOCUS | ₹17,417.1 Cr | -4.2% | -11.2% | 88.1% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,514.5 Cr | -2.2% | -4.4% | -7.5% | Stock Analytics | |
| INDEGENE | ₹13,036.4 Cr | 4.9% | 6.4% | -10.3% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -0.3% |
31.8% |
45.9% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses